Canopy Growth Corporation (CGC) Stock

Canopy Growth Corporation (CGC) is a Healthcare stock trading at $0.97 (as of 2026-06-18), with a market capitalization of $411.87M and a trailing P/E of -1.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Canopy Growth Corporation, with its subsidiaries, produces, distributes, and sells cannabis and hemp-based products, including dried flower, extracts and concentrates, beverages, gummies, and vapes. It operates primarily through a Global Cannabis segment and an Other Consumer Products segment, serving recreational and medical customers mainly in Canada, the United States, and Germany.

Valuation — source: SEC EDGAR (first-party)
Price	$0.97
Market Cap	$411.87M
P/E Ratio	-1.1
EV / EBITDA	-1.9
Price / Book	0.58
Price / Sales	1.42
DCF Value (model)	$-2.48
DCF Upside vs Price	-356.3%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$284.60M
Net Margin	-92.4%
Return on Equity	-37.7%
Debt / Equity	0.33
Current Ratio	3.34
Revenue Growth (YoY)	5.8%
EPS Growth (YoY)	-84.2%
FCF Growth (YoY)	-60.8%

Financial Health — source: SEC EDGAR
Altman Z-Score	-13.18 (distress)
Piotroski F-Score	4/9 (moderate)

Valuation vs Sector & Industry
Stock P/E	-1.1
Sector P/E (Healthcare)	21.0
Industry P/E (Pharmaceutical Products)	17.3
vs Sector	-105.2%
vs Industry	-106.3%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	Tidal Investments LLC ($7.69M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Pharmaceutical Products
CEO	Luc Mongeau
Employees	1,029
Country	CA
IPO Date	2014-04-07

Related Companies (Business model: Branded Consumer (CPG, Staples, Beauty, Alcohol, Pet, Nicotine); 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.